Pluri (PLUR) Gross Profit (2011 - 2025)
Pluri (PLUR) reported Gross Profit of $86000.0 for Q4 2025, down 22.52% year-over-year from $111000.0 in Q4 2024, and down 25.22% quarter-over-quarter from $115000.0 in Q3 2025.
Pluri (PLUR) Gross Profit (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 12 years of Gross Profit data on file, last reported at $86000.0 in Q4 2025.
- Gross Profit for Q4 2025 came in at $86000.0, down 22.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $544000.0 (up 14.77% YoY), and the FY2025 annual result was $654000.0, up 103.11% from the prior year.
- Gross Profit fell to $86000.0 in Q4 2025 per PLUR's latest filing, from $115000.0 in the prior quarter.
- Over five years, Gross Profit peaked at $207000.0 in Q2 2025 and troughed at $54000.0 in Q3 2023.
- A 3-year average of $117700.0 and a median of $108000.0 in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2024 and 2025: Gross Profit surged 270.37% in 2024, then tumbled 42.5% in 2025.
- A 3-year view of Gross Profit shows it stood at $105000.0 in 2023, then grew by 5.71% to $111000.0 in 2024, then retreated by 22.52% to $86000.0 in 2025.
- Business Quant data shows PLUR's Gross Profit at $86000.0 in Q4 2025, $115000.0 in Q3 2025, and $207000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Mar 31, 2024 | 71,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Dec 31, 2023 | 105,000.00 |
| Sep 30, 2023 | 54,000.00 |
| Sep 30, 2023 | 54,000.00 |